Cumberland Pharmaceuticals Inc.
CPIX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33,323 | $25,595 | $32,768 | $69,606 |
| - Cash | $17,964 | $18,322 | $19,758 | $27,041 |
| + Debt | $20,572 | $18,428 | $20,959 | $16,060 |
| Enterprise Value | $35,931 | $25,702 | $33,969 | $58,624 |
| Revenue | $37,868 | $39,553 | $42,011 | $35,985 |
| % Growth | -4.3% | -5.9% | 16.7% | – |
| Gross Profit | $31,282 | $33,486 | $32,892 | $27,174 |
| % Margin | 82.6% | 84.7% | 78.3% | 75.5% |
| EBITDA | $182 | $2,486 | $333 | -$858 |
| % Margin | 0.5% | 6.3% | 0.8% | -2.4% |
| Net Income | -$6,480 | -$6,279 | -$5,570 | -$3,508 |
| % Margin | -17.1% | -15.9% | -13.3% | -9.7% |
| EPS Diluted | -0.46 | -0.44 | -0.38 | -0.24 |
| % Growth | -4.5% | -15.8% | -58.3% | – |
| Operating Cash Flow | -$612 | $6,094 | $8,453 | $6,342 |
| Capital Expenditures | -$180 | -$453 | -$2,074 | -$354 |
| Free Cash Flow | -$792 | $5,641 | $6,380 | $5,988 |